August 20, 2024 C-Path Receives Data Transfer from The Champ Foundation Registry C-Path has received its first data transfer of natural history data on single large-scale mitochondrial DNA...
August 15, 2024 Clinical Outcome Assessments — Second Public Discussion Enjoy the recording and slides from this August 15 CP-RND webinar.
August 14, 2024 C-Path to Host Tucson after5 Techmixer at Headquarters C-Path and the Arizona Technology Council invite you on August 14, from 5:30-7:30...
August 13, 2024 C-Path’s TRxA Announces $250,000 Grant for Drug Development Project on Antibiotic-Resistant Gram-Negative Bacteria TUCSON, Ariz. August 13, 2024– Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced toda
August 12, 2024 CPP CODR Database — Data Standards: Why are they needed? C-Path's Critical Path for Parkinson's (CPP) Consortium consultant Anne Pedata led this webinar on...
August 12, 2024 C-Path Welcomes CuraSen As Newest CPP Member C-Path is thrilled to welcome CuraSen Therapeutics as the newest member of its Critical Path for Parkinson’s Consortium.
August 8, 2024 C-Path’s TRxA Announces $250,000 Award for Drug Development Project in ALS TUCSON, Ariz., August 8, 2024 – Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced tod
August 6, 2024 C-Path Welcomes New Advisory Members to Alpha-1 Antitrypsin Deficiency Consortium C-Path's Critical Path for Alpha-1 Antitrypsin Deficiency (CPA-1) consortium today announced the addition of several...
July 31, 2024 Meet the Team — Q&A with Clinical Outcome Assessment Scientist Cole Ayasse I am a Clinical Outcome Assessment (COA) Scientist in the COA Program at C-Path.
July 29, 2024 A Modern Curriculum for Training Scientists in Model-Informed Drug Development: Progress Report on FDA Grant to Train Regulatory Scientists C-Path and experienced private sector partners collaborated with global health organizations to create didactic video materials...
